These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26031365)

  • 1. Serum Proteome Signature of Radiation Response: Upregulation of Inflammation-Related Factors and Downregulation of Apolipoproteins and Coagulation Factors in Cancer Patients Treated With Radiation Therapy--A Pilot Study.
    Widlak P; Jelonek K; Wojakowska A; Pietrowska M; Polanska J; Marczak Ł; Miszczyk L; Składowski K
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1108-1115. PubMed ID: 26031365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression.
    Pietrowska M; Polańska J; Suwiński R; Wideł M; Rutkowski T; Marczyk M; Domińczyk I; Ponge L; Marczak L; Polański A; Widłak P
    Int J Oncol; 2012 Jan; 40(1):148-56. PubMed ID: 21894432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-related changes in serum proteome profiles detected by mass spectrometry in blood of patients treated with radiotherapy due to larynx cancer.
    Widłak P; Pietrowska M; Wojtkiewicz K; Rutkowski T; Wygoda A; Marczak L; Marczyk M; Polańska J; Walaszczyk A; Domińczyk I; Składowski K; Stobiecki M; Polański A
    J Radiat Res; 2011; 52(5):575-81. PubMed ID: 21768750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy-related changes in serum proteome patterns of head and neck cancer patients; the effect of low and medium doses of radiation delivered to large volumes of normal tissue.
    Widłak P; Pietrowska M; Polańska J; Rutkowski T; Jelonek K; Kalinowska-Herok M; Gdowicz-Kłosok A; Wygoda A; Tarnawski R; Składowski K
    J Transl Med; 2013 Dec; 11():299. PubMed ID: 24304975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study.
    Abramowicz A; Wojakowska A; Gdowicz-Klosok A; Polanska J; Rodziewicz P; Polanowski P; Namysl-Kaletka A; Pietrowska M; Wydmanski J; Widlak P
    J Transl Med; 2015 Sep; 13():304. PubMed ID: 26376850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy.
    Pervez N; Small C; MacKenzie M; Yee D; Parliament M; Ghosh S; Mihai A; Amanie J; Murtha A; Field C; Murray D; Fallone G; Pearcey R
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):57-64. PubMed ID: 19395192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity-modulated radiation therapy or stereotactic ablative body radiotherapy.
    Frey B; Mika J; Jelonek K; Cruz-Garcia L; Roelants C; Testard I; Cherradi N; Lumniczky K; Polozov S; Napieralska A; Widlak P; Gaipl US; Badie C; Polanska J; Candéias SM
    Strahlenther Onkol; 2020 Nov; 196(11):1018-1033. PubMed ID: 32519025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionizing radiation affects the composition of the proteome of extracellular vesicles released by head-and-neck cancer cells in vitro.
    Abramowicz A; Wojakowska A; Marczak L; Lysek-Gladysinska M; Smolarz M; Story MD; Polanska J; Widlak P; Pietrowska M
    J Radiat Res; 2019 May; 60(3):289-297. PubMed ID: 30805606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial-Body Irradiation in Patients with Prostate Cancer Treated with IMRT Has Little Effect on the Composition of Serum Proteome.
    Pietrowska M; Jelonek K; Polanska J; Wojakowska A; Marczak L; Chawinska E; Chmura A; Majewski W; Miszczyk L; Widlak P
    Proteomes; 2015 Jun; 3(3):117-131. PubMed ID: 28248265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.
    Fuller DB; Wurzer J; Shirazi R; Bridge SS; Law J; Mardirossian G
    Pract Radiat Oncol; 2015; 5(6):e615-23. PubMed ID: 26059509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic effects of ionizing radiation at the proteome and metabolome levels in the blood of cancer patients treated with radiotherapy: the influence of inflammation and radiation toxicity.
    Jelonek K; Pietrowska M; Widlak P
    Int J Radiat Biol; 2017 Jul; 93(7):683-696. PubMed ID: 28281355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of serum proteome components associated with progression of non-small cell lung cancer.
    Pietrowska M; Jelonek K; Michalak M; Roś M; Rodziewicz P; Chmielewska K; Polański K; Polańska J; Gdowicz-Kłosok A; Giglok M; Suwiński R; Tarnawski R; Dziadziuszko R; Rzyman W; Widłak P
    Acta Biochim Pol; 2014; 61(2):325-31. PubMed ID: 24872961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application value of reduced field intensity modulated radiation therapy for advanced cervical cancer].
    DU XL; Sheng XG; Wang C; Yu H; Song QQ; Pan CX
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):925-31. PubMed ID: 24506963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.
    Krauss DJ; Hu C; Bahary JP; Souhami L; Gore EM; Chafe SM; Leibenhaut MH; Narayan S; Torres-Roca J; Michalski J; Zeitzer KL; Donavanik V; Sandler H; McGowan DG; Jones CU; Shipley WU
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):863-73. PubMed ID: 26104939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of circulatory cytokines in patients undergoing intensity-modulated radiotherapy (IMRT) for adenocarcinoma of the prostate and association with acute RT-induced toxicity: A prospective clinical study.
    Singh J; Sohal SS; Ahuja K; Lim A; Duncan H; Thachil T; De Ieso P
    Cytokine; 2020 Jul; 131():155108. PubMed ID: 32330791
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of percentage of preradiation needle biopsies with adenocarcinoma and total radiation dose on the pathologic response of unfavorable prostate adenocarcinoma.
    Goldstein NS; Kestin LL; Vicini FA; Martinez AA
    Am J Clin Pathol; 2002 Jun; 117(6):927-34. PubMed ID: 12047145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer.
    Cheng JC; Schultheiss TE; Nguyen KH; Wong JY
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):351-7. PubMed ID: 18164841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.